Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D2TN
|
||||
Former ID |
DIB005104
|
||||
Drug Name |
Rimexolone
|
||||
Synonyms |
Rimexolone (sustained release intra-articular steroid suspension, Plexis, arthritis)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Auritec Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H34O3
|
||||
InChI |
InChI=1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1
|
||||
InChIKey |
QTTRZHGPGKRAFB-OOKHYKNYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980520, 11056486, 11467048, 11468168, 11486786, 12014133, 14804034, 14828819, 39341090, 47207390, 47871005, 47871006, 47871007, 48170707, 49699253, 50123981, 56463550, 57359468, 80240860, 85788089, 92126045, 103770600, 103914672, 114156025, 121363716, 124801082, 134224655, 135000880, 137005248, 141792894, 164233438, 164764869, 175267976, 175612108, 178103677, 179149417, 226767286, 244890192
|
||||
Target and Pathway | |||||
Target(s) | Steroid hormone receptor ERR1 | Target Info | Modulator | [543900] | |
References | |||||
Ref 522023 | ClinicalTrials.gov (NCT00471419) Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye. U.S. National Institutes of Health. | ||||
Ref 542105 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7099). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.